Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mathias Uhlén

OTHER INVESTOR TYPE
2 INVESTMENTS
1 PORTFOLIO
1 EXITS
Description

Mr. Mathias Uhlén is a Co-Founder and serves as Chairman at Atlas Antibodies. He co-founded and served as Deputy Chairman and Scientific Advisor at Affibody. He serves as Board Member at Bure Equity. Dr. Uhlén serves as Professor at Royal Institute of Technology. Dr. Uhlén serves as a Board Member at SweTree Technologies and Affibody. Mathias Uhlén is Professor of Microbiology at the Royal Institute of Technology, Stockholm, Sweden. Prof Uhlén is member of the Royal Swedish Academy of Engineering Science (IVA) and he is also a member of the Royal Swedish Academy of Science. He also serves as Board Member at Bure Equity.

Primary Investor Type
Angel (individual)

Mathias Uhlén Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Mindforce Game Lab 01-Dec-2019 Early Stage VC Entertainment Software Generating Revenue 0000000 000é0 00.0
000000000 00000000 29-May-2007 00000 00000 00.000 Drug Discovery Generating Revenue/Not Profitable 0000000 000é0 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mathias Uhlén’s full profile, request a free trial.

Mathias Uhlén Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00000000 23-Nov-2016 000 000.00 Completed
To view this investor’s complete exits history, request access »

Mathias Uhlén Team (1)

Name Title Deals Funds Boards Office Contact
Info
Mathias Uhlén Ph.D Angel Investor 0 0 Stockholm, Sweden

Mathias Uhlén Co-Investors (2)

Name With Exits Lead Partner
Partnerinvest Norr 1 0
Petter Mikaelsson 0 0
To view this investor’s complete co-investor history, request access »